Bullfrog AI Holdings Inc. (BFRG)
BFRG trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.5689
-2.55% on the day
Market cap
$10.5M
Nano cap
Revenue · 2025
$117K
Prior year not contiguous
Net income · 2025
-$6.5M
-5569.6% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | BFRG on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2023 |
| SEC CIK | 0001829247 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $117K |
| Net income | -$6.5M |
| Operating income | -$6.6M |
| Net margin | -5569.6% |
| Operating margin | -5652.4% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $2.2M |
| Total assets | $2.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 90.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-07-06 |
| Latest annual report | 10-K | 2026-03-19 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K | 2026-08-20 |
| Latest proxy | DEFA14A | 2026-05-01 |
Source: SEC EDGAR submissions feed, 205 recent filings. All filings on EDGAR.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| BFRGW | Bullfrog AI Holdings Inc. Warrants | $0.1033 |
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| LTRN | Lantern Pharma Inc. | $0.7107 | -3.57% | $10.6M |
| BIVI | BioVie Inc. | $1.20 | -9.09% | $10.4M |
| BLRX | BioLineRx Ltd. | $2.17 | 0.00% | $10.8M |
| GDTC | CytoMed Therapeutics Limited | $0.8700 | +7.22% | $10.3M |
| PHIO | Phio Pharmaceuticals Corp. | $0.9345 | +1.36% | $10.9M |
| KPRX | Kiora Pharmaceuticals Inc. | $2.47 | -3.52% | $10.9M |
| ENSC | Ensysce Biosciences Inc. | $0.5725 | +2.99% | $11.1M |
| ACTU | Actuate Therapeutics Inc. | $0.4663 | -27.56% | $11.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier